FXR & LXR
FXR (farnesoid X receptor) is a nuclear receptor that binds to hormone response elements on DNA, regulating the expression of certain genes when it is activated.
Products for FXR & LXR
- Cat.No. Product Name Information
- GC31386 (-)-PX20606 trans isomer ((-)-PX-102 trans isomer) (-)-PX20606 trans isomer ((-)-PX-102 trans isomer) is a FXR agonist with EC50s of 18 and 29 nM for FXR in FRET and M1H assay, respectively.
- GC34965 (20S)-Protopanaxatriol An active ginsenoside metabolite
- GC14972 22(R)-hydroxy Cholesterol endogenous agonist for LXRs
- GC18270 22(S)-hydroxy Cholesterol A synthetic oxysterol and LXR modulator
-
GC17827
24(R)-hydroxy Cholesterol
LXRα and LXRβ nuclear receptors activator
-
GC40571
24(S),25-epoxy Cholesterol
24(S),25-epoxy Cholesterol is an oxysterol and the most abundant oxysterol in mouse ventral midbrain.
-
GC18076
24(S)-hydroxy Cholesterol
LXRα and LXRβ nuclear receptors activator
- GC33673 24-Hydroxycholesterol 24-Hydroxycholesterol is a natural sterol, which serves as a positive allosteric modulator of N-Methyl-d-Aspartate (NMDA) receptorsR, and a potent activator of the transcription factors LXR.
- GC13431 24α-methyl Cholesterol 24α-methyl Cholesterol is a plant sterol with cholesterol lowering and anticarcinogenic effects.
- GC13887 25(R)-27-hydroxy Cholesterol 25(R)-27-hydroxy Cholesterol is a selective estrogen receptor modulator and an agonist of the liver X receptor.
- GC11700 25(S)-27-hydroxy Cholesterol liver x receptors (LXRα and LXRβ) activator
- GC40053 5α,6α-epoxy Cholestanol An oxysterol and a metabolite of cholesterol produced by oxidation
- GC17059 Acetyl Podocarpic Acid Anhydride LXR agonist
-
GC40024
Altenusin
Altenusin is a polyphenol fungal metabolite originally isolated from the fungus Alternaria that has diverse biological activities.
-
GC30842
Androsterone (5α-Androstan-3α-ol-17-one)
An androgenic steroid
- GC32801 AZ876 An LXR agonist
- GC30565 BAR502 A dual agonist of GP-BAR1 and FXR
- GC42943 Bischloroanthrabenzoxocinone Bacterial type II fatty acid synthesis (FAS-II) is mediated by a series of enzymes, each of which may be targeted by potential antibiotics.
- GC31372 BMS-779788 (EXEL04286652) BMS-779788 (EXEL04286652) is a LXR partial agonist with IC50 values of 68 nM for LXRα and 14 nM for LXRβ.
- GC48426 CAY10771 A dual agonist of FXR and PPARδ
- GC17985 Chenodeoxycholic Acid nuclear receptors(FXR) activator
- GC48424 Chenodeoxycholic Acid 24-Acyl-β-D-Glucuronide A metabolite of CDCA
- GC49853 Chenodeoxycholic Acid 3-Glucuronide A metabolite of CDCA
- GC48595 Chenodeoxycholic Acid MaxSpec® Standard A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications
- GC68212 Chenodeoxycholic acid-13C
- GC47076 Chenodeoxycholic Acid-d4 A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications
- GC18212 Cilofexor Cilofexor inhibits binding of a synthetic peptide, comprising residues 676-700 of the steroid receptor coactivator 1 (SRC-1), to the farnesoid X receptor (FXR; EC50 = <25 nM in a FRET activity assay).
- GC65260 EDP-305 EDP-305 is an orally active, potent and selective farnesoid X receptor (FXR) agonist, with EC50 values of 34 nM (chimeric FXR in CHO cells) and 8 nM (full-length FXR in HEK cells).
- GC10755 Fexaramine farnesoid X receptor agonist
- GC40911 Glycine-β-muricholic Acid Glycine-β-muricholic Acid, a bile acid, is a potent, sable, intestine-selective and oral bioactive farnesoid X receptor (FXR) inhibitor that may be a candidate for the treatment of metabolic disorders.
- GC45466 Glyco-Obeticholic Acid
-
GC31331
GSK2033
An antagonist of LXRα and LXRβ
- GC48610 GSK3987 A dual agonist of LXRα and LXRβ
- GC17658 Guggulsterone Broad spectrum steroid receptor ligand
- GC16964 GW3965 An orally-active agonist of LXRα and LXRβ
- GC17696 GW3965 HCl GW3965 HCl is a potent and selective liver X receptor (LXR) agonist with EC50s of 190 nM and 30 nM for hLXRα and hLXRβ, respectively.
- GC10975 GW4064 GW4064, as a synthetic FXR agonist, was used for treatment of cholestatic liver diseases, metabolic syndrome and alcoholic liver disease.
- GC32742 INT-767 INT-767 is a dual farnesoid X receptor (FXR)/TGR5 agonist with mean EC50s of 30 and 630 nM, respectively.
- GC65936 Larsucosterol (trimethylamine) Larsucosterol (DUR-928) trimethylamine, a cholesterol metabolite, is a potent liver X receptor (LXR) antagonist. Larsucosterol trimethylamine as a potent endogenous regulator decreases lipogenesis. Larsucosterol trimethylamine inhibits the cholesterol biosynthesis via decreasing mRNA levels and inhibiting the activation of SREBP-1.
- GC36499 LXRβ agonist-2 LXRβ agonist-2 is a highly potent and β-selective liver X receptor (LXRβ) agonist with EC50 of 7 nM, displays 28.5-fold selectivity over LXRα (EC50=200 nM) and used in the treatment of atherosclerosis.
- GC13954 LXR-623 Liver X-receptor agonist
-
GC19421
LY2562175
LY2562175 is a potent and selective?FXR?agonist with an?EC50?of 193 nM
-
GC31314
Nagilactone B
Nagilactone B is a liver X receptor (LXR) agonist.
-
GC69541
NDB
NDB is a selective antagonist of human FXRα (hFXRα) that can effectively regulate the transcription of downstream genes of FXRα. NDB can be used in anti-diabetes research.
-
GC34686
Nidufexor
An FXR partial agonist
- GC14158 Obeticholic Acid A FXR agonist with anticholeretic activity
- GC31395 PX20606 trans racemate (PX-102 trans racemate) PX20606 trans racemate (PX-102 trans racemate) (PX-102 trans racemate) is a FXR agonist with EC50s of 32 and 34 nM for FXR in FRET and M1H assay, respectively.
- GC19448 RGX-104 RGX-104 is a small-molecule LXR agonist that modulates innate immunity via transcriptional activation of the ApoE gene.
- GC37525 RGX-104 free Acid
- GC32054 Rovazolac Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
- GN10024 Saikosaponin A
- GC37630 Sevelamer Sevelamer is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease; consists of polyallylamine that is crosslinked with epichlorohydrin.
- GC11885 Sevelamer HCl Sevelamer HCl is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease; consists of polyallylamine that is crosslinked with epichlorohydrin.
- GC45567 SR 1903
- GC13680 SR-9243 inverse agonist of LXR
- GC14638 SR9238 inverse agonist of the two LXR isoforms, LXRα and LXRβ
- GC10596 T0901317 Liver X receptor agonist,potent and selective
- GC44999 Tauro-α-muricholic Acid (sodium salt) Tauro-α-muricholic acid (TαMCA) is an antagonist of the farnesoid X receptor (FXR; IC50 = 28 μM) and a taurine-conjugated form of the murine-specific primary bile acid α-muricholic acid.
- GC49011 Tauro-α-muricholic Acid-d4 (sodium salt) An internal standard for the quantification of tauro-α-muricholic acid
- GC45000 Tauro-β-muricholic Acid (sodium salt) Tauro-β-muricholic Acid sodium (T-βMCA sodium), a endogenous metabolite, is a competitive and reversible farnesoid X receptor (FXR) antagonist, with an IC50 of 40 μM.
- GC49012 Tauro-β-muricholic Acid-d4 (sodium salt) An internal standard for the quantification of tauro-β-muricholic acid
- GC44998 Tauro-Obeticholic Acid Tauro-obeticholic acid is a taurine-conjugated form of obeticholic acid, which is a farnesoid X receptor (FXR) agonist and semisynthetic derivative of chenodeoxycholic acid.
- GC19363 Tropifexor Tropifexor is a novel and highly potent agonist of FXR with an EC50 of 0.2 nM.
- GC32459 XL041 (BMS-852927) XL041 (BMS-852927) (BMS-852927) is an LXRβ-selective agonist.
- GC10760 XL335 XL335 (FXR-450) is a potent, selective, and orally bioavailable FXR agonist with EC50 of 4 nM.